Comparison of Two NN1250 Formulations in Subjects With Type 1 Diabetes
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of the trial is to investigate the pharmacodynamic
properties (effect) by comparing two NN1250 (insulin degludec, IDeg) formulations in subjects
with type 1 diabetes.